文献速递鼻科咽喉与嗓音

内镜鼻窦手术改善阿司匹林加重性呼吸系统疾病患者的阿司匹林治疗反应

Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients.
PubMed 文献 · Int Forum Allergy Rhinol · 2019-09-30

该研究前瞻性评估内镜鼻窦手术(ESS)对阿司匹林加重性呼吸系统疾病(AERD)患者阿司匹林脱敏和治疗效果的影响。40例有ESS史但术前阿司匹林治疗失败的患者中,24例后续接受ESS并再次脱敏,全部耐受第二轮治疗;术前ESS可能将无反应者转为有反应表型。

要点

  • 术前ESS可提高AERD患者阿司匹林脱敏和治疗的耐受性与反应性。
  • 基线血清IgE较高的患者可能从ESS后尽早行阿司匹林脱敏中获益。
  • 非 responders 更常见于非裔美国人且基线IgE水平更高。

核心结论

  • 术前ESS增强AERD患者对阿司匹林治疗的反应,可能将术前治疗失败者转为更 responsive 的表型。

研究设计与样本

  • 前瞻性队列研究,纳入40例有远期ESS史(平均48个月)且术前阿司匹林治疗失败的AERD患者,评估ESS前后4、12、24周的ACT、RQLQ及呼吸功能等指标。

主要发现

  • nonresponders 基线IgE水平为252 kU/L,responders 为87 kU/L(p < 0.01)。
  • 24例(9例 responders 和15例 nonresponders)后续接受ESS,术后3-4周再次脱敏,全部耐受第二轮脱敏和治疗。
  • 初次阿司匹林治疗 associated with nonresponders 的IgE显著升高,而第二轮脱敏治疗后IgE无显著升高。

临床怎么用

  • 对AERD且阿司匹林治疗失败的患者,可考虑先行ESS再行阿司匹林脱敏和治疗。
  • 基线血清IgE较高的患者可能尤其受益于ESS后尽早启动阿司匹林脱敏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aspirin desensitization and treatment benefits most patients with aspirin-exacerbated respiratory disease (AERD), although some patients fail therapy. Our objective was to assess whether recent endoscopic sinus surgery (ESS) improved aspirin treatment outcomes in AERD patients who initially failed aspirin therapy. METHODS: Outcomes of aspirin desensitization and treatment in AERD patients prospectively enrolled were assessed preoperatively and at 4, 12, and 24 weeks after ESS by determining changes in Asthma Control Test (ACT) and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores and respiratory function. Biomarkers, including fractional excretion of nitric oxide (FeNO), spirometry, nasal inspiratory peak flow (NPF), immunoglobulin E (IgE), and eosinophil count, were measured. RESULTS: Nineteen patients who benefited (responders) and 21 patients who failed (nonresponders) preoperative aspirin treatment with a distant history of ESS (mean, 48 months) were identified. Nonresponders were more likely to be African American (71%, p < 0.01) and have higher baseline IgE levels (252 kU/L vs 87 kU/L in responders, p < 0.01). 24 of the 40 patients (nine responders and 15 non-responders) required subsequent ESS and underwent another aspirin desensitization 3-4 weeks after ESS. All 24 patients tolerated a second round of aspirin desensitization and treatment. The primary aspirin therapy was associated with a significant increase in IgE in nonresponders, but there was no significant increase in IgE after the second aspirin desensitization and treatment. CONCLUSION: Antecedent ESS enhances aspirin treatment responses in AERD patients and may convert patients who failed aspirin treatment before surgery to a more responsive phenotype after ESS. Patients with higher baseline serum IgE levels may benefit from ESS performed shortly before aspirin desensitization and therapy.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Shah SJ, Abuzeid WM, Ponduri A, et al. Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients. Int Forum Allergy Rhinol. 2019. PMID: 31569308. doi:10.1002/alr.22418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。